Biotechnology Industry

Colossal Biosciences Research and Development Startups Pharmaceutical Companies Investment Drug Development Startup Companies Funding Clinical Research Conservation Startups Clinical Trials Clonorgan Biotechnology Collaborations De-extinction Companies Corporate Social Responsibility Pharmaceuticals Gene Editing Companies Regulatory Approval Corporate Sustainability DNA Synthesis Providers Manufacturing Hubs Investment in Conservation Partnerships Clinical Development Pest Control Services Investment Strategies Drug Development Costs Commercial Applications Patent Disputes Synthetic Biology Startups Company Profiles Patent Litigation Investment Opportunities Genetic Engineering Firms Commercial-stage Companies Conservation Funding Food Industry Gene Therapy Production Facilities Start-ups

Life Biosciences Doses First Patient With Eye Reprogramming Gene Therapy

The study uses a doxycycline-controlled three-gene system to treat glaucoma with a reversible safety switch to limit gene activity.

Cortical Labs Shows Human Neuron Computer Playing Doom, Invites Developers

FDA Clears Arrowhead’s Redemplo for FCS, Marking the Biotech’s First Approval

Microsoft-Led Study Exposes AI Biosecurity Gap as Patches Lift Detection to 97%

E. coli Strain Engineered With Record-Compressed 57-Codon Genome